drugset / Trial / NCT01530243

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

NCT01530243

Phase 2/3 Completed 104 enrolled Urmia University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the investigators study is to evaluate whether alpha-blockers such as terazosin and anti-cholinergics such as tolterodine can be relieve the DJ-stent related symptoms.

Timeline

Start
2012-01
Primary completion
2012-08
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terazosin Small molecule 2 mg
Comparator Tolterodine Small molecule 2 mg